Keyphrases
Clinical Trials
100%
Bone Marrow Cells
100%
CD133
100%
Myocardial Regeneration
100%
Ischemic Cardiomyopathy
66%
Recent Advances
33%
Endothelial Progenitor Cells
33%
Clinical Application
33%
Cell Therapy
33%
Advanced Stage
33%
Therapeutic Potential
33%
Revascularization
33%
Therapeutic Agents
33%
Transmembrane Protein
33%
Ischemic Heart Disease
33%
Non-ischemic
33%
Coronary Revascularization
33%
Endothelial Progenitors
33%
Bone Marrow-derived Endothelial Progenitor Cells
33%
Optimal Medical Treatment
33%
Angiogenic Property
33%
Medicine and Dentistry
Endothelial Progenitor Cell
100%
Clinical Trial
100%
Stem Cell
100%
Regeneration
100%
Ischemic Cardiomyopathy
100%
Combination Therapy
50%
In Vitro
50%
Cell Therapy
50%
Membrane Protein
50%
Therapeutic Agent
50%
Ischemic Heart Disease
50%
Heart Muscle Revascularization
50%
Biochemistry, Genetics and Molecular Biology
Clinical Trial
100%
Stem Cell
100%
CD133
100%
Endothelial Progenitor Cell
66%
Membrane Protein
33%
Transmembrane Protein
33%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Ischemic Cardiomyopathy
100%
Membrane Protein
50%
Combination Therapy
50%
Ischemic Heart Disease
50%
Immunology and Microbiology
Stem Cell
100%
Endothelial Progenitor Cell
100%
Revascularization
50%